Monte Rosa Therapeutics, Inc. (GLUE)
14.52
+0.74
(+5.41%)
USD |
NASDAQ |
Aug 25, 12:56
Monte Rosa Therapeutics Total Assets (Quarterly) : 691.16M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 691.16M |
| March 31, 2026 | 736.43M |
| December 31, 2025 | 448.66M |
| September 30, 2025 | 459.84M |
| June 30, 2025 | 359.59M |
| March 31, 2025 | 393.20M |
| December 31, 2024 | 438.73M |
| September 30, 2024 | 315.08M |
| June 30, 2024 | 344.11M |
| March 31, 2024 | 266.75M |
| December 31, 2023 | 303.76M |
| September 30, 2023 | 252.10M |
| Date | Value |
|---|---|
| June 30, 2023 | 278.62M |
| March 31, 2023 | 309.03M |
| December 31, 2022 | 342.39M |
| September 30, 2022 | 357.60M |
| June 30, 2022 | 365.06M |
| March 31, 2022 | 346.00M |
| December 31, 2021 | 366.33M |
| September 30, 2021 | 384.05M |
| June 30, 2021 | 368.94M |
| March 31, 2021 | 180.60M |
| December 31, 2020 | 49.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Nurix Therapeutics, Inc. | 535.54M |
| Gilead Sciences, Inc. | 49.36B |
| Ironwood Pharmaceuticals, Inc. | 285.13M |
| Capricor Therapeutics, Inc. | 368.74M |
| Cue Biopharma, Inc. | 30.71M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 203.88M |
| Shareholders Equity (Quarterly) | 487.28M |
| Debt to Equity Ratio | 0.078 |
| Current Ratio | 10.58 |
| Net Debt Paydown Yield | 0.04% |